Physical Therapists in Dover Afb, DE Accepting Medicare
4 Physical Therapists found. Showing 1 - 4
 Denise Edith Lemon, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-677-2568 |
 Dr. Matthew Savini, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-677-2568 |
Vanessa F Scheirer, PT, DPT, OCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Tuskegee Blvd, Dover Afb, DE 19902 Phone: 302-677-6198 |
Mr. Winston Ryder Witherell, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 300 Tuskegee Blvd, 436 Medical Group, Dover Afb, DE 19902 Phone: 302-677-2568 Fax: 302-677-2540 |
News Archive
Researchers develop novel method to store microfluidic devices for CD4 T cell testing
Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art medical equipment poses a number of challenges. Inspired by pregnancy tests, researchers from Florida Atlantic University, Stanford University, and Baskent University in Turkey, have developed a novel method to store microfluidic devices for CD4 T cell testing in extreme weather conditions for up to six months without refrigeration.
Provectus commences PH-10 Phase 2c trial for psoriasis
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 2c clinical trial of PH-10 for psoriasis. This multicenter, randomized controlled Phase 2c study is expected to enroll up to 90 subjects at four different sites, beginning in late December.
Excessive gestational weight gain affects women in the long run
Unhealthy weight gain in pregnancy has been linked with postpartum weight retention but until now its long-term effects had been understudied in low-income and minority populations who are at high risk for obesity.
USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection
EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has issued two new patents covering methods of treatment and methods of preparation for the Company's Ready-to-Use (RTU) Cardene® I.V. (nicardipine hydrochloride) Premixed Injection.
Changes in certain brain networks seem to be linked to suicide risk
Scientists have identified patterns of brain activity that may be associated with increased risk of suicide.
› Verified 2 days ago